IL91335A0 - Dna sequence and hepadnavirus - Google Patents

Dna sequence and hepadnavirus

Info

Publication number
IL91335A0
IL91335A0 IL91335A IL9133589A IL91335A0 IL 91335 A0 IL91335 A0 IL 91335A0 IL 91335 A IL91335 A IL 91335A IL 9133589 A IL9133589 A IL 9133589A IL 91335 A0 IL91335 A0 IL 91335A0
Authority
IL
Israel
Prior art keywords
hepadnavirus
dna sequence
dna
sequence
Prior art date
Application number
IL91335A
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of IL91335A0 publication Critical patent/IL91335A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL91335A 1988-08-16 1989-08-16 Dna sequence and hepadnavirus IL91335A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23281188A 1988-08-16 1988-08-16

Publications (1)

Publication Number Publication Date
IL91335A0 true IL91335A0 (en) 1990-03-19

Family

ID=22874695

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91335A IL91335A0 (en) 1988-08-16 1989-08-16 Dna sequence and hepadnavirus

Country Status (8)

Country Link
EP (1) EP0380656A1 (en)
AU (1) AU4315689A (en)
DK (1) DK93390A (en)
FI (1) FI901876A0 (en)
IE (1) IE892640L (en)
IL (1) IL91335A0 (en)
WO (1) WO1990002176A1 (en)
ZA (1) ZA896246B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016420A1 (en) * 1990-04-20 1991-10-31 The General Hospital Corporation Methods of preventing viral replication
US5610050A (en) * 1990-04-20 1997-03-11 The General Hospital Corporation Methods of preventing viral replication
FR2716459B1 (en) * 1994-02-22 1996-05-10 Univ Paris Curie Host-vector system usable in gene therapy.
US5869248A (en) * 1994-03-07 1999-02-09 Yale University Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences
US6057153A (en) * 1995-01-13 2000-05-02 Yale University Stabilized external guide sequences
US5683873A (en) * 1995-01-13 1997-11-04 Innovir Laboratories, Inc. EGS-mediated inactivation of target RNA
DE19517532C2 (en) * 1995-05-12 1999-10-28 Max Planck Gesellschaft HBV vectors and cells for their delivery
US5980901A (en) * 1996-09-18 1999-11-09 The Board Of Regents Of The University Of Texas System Viral defective interfering particles and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861588A (en) * 1985-02-05 1989-08-29 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers

Also Published As

Publication number Publication date
DK93390D0 (en) 1990-04-11
EP0380656A1 (en) 1990-08-08
ZA896246B (en) 1990-06-27
FI901876A0 (en) 1990-04-12
AU4315689A (en) 1990-03-23
DK93390A (en) 1990-06-15
WO1990002176A1 (en) 1990-03-08
IE892640L (en) 1990-02-16

Similar Documents

Publication Publication Date Title
ZA904121B (en) Enzymes and their use
GB2183886B (en) Microbook and its associated bookgenerator unit
EP0355247A3 (en) Compressed-molded preparations
GB2210043B (en) Phosphinylcycloalkylcarbonyl and phosphinylcycloalkenylcarbonyl dipeptides
EP0204659A3 (en) Polyepoxydes and their use
GR860078B (en) Spiro - dioxolanes - dithiolanes and oxothiolanes
GB8724412D0 (en) Protein
EP0313969A3 (en) Tripeptide derivatives and antiplasmin agents containing the same
DE3660256D1 (en) Camphor-di-thiolene-complexes and their use
EP0255801A3 (en) Anilinotriazines and their use
IL91335A0 (en) Dna sequence and hepadnavirus
ZA894800B (en) Proteins and nucleic acids
HUT54932A (en) Shear insert and insert-holding arrangement
NZ227594A (en) Human interleukin-1alpha and preparations thereof
EP0465132A3 (en) Dna and its use
EP0316934A3 (en) Muramyl peptide derivatives and use thereof
ZA895461B (en) Modified proteins
GB8818150D0 (en) Gene modification
GB8816095D0 (en) Protein
KR910007551B1 (en) Polyethylene terephchalate and its use
EP0233740A3 (en) Aerocavin and aerocyanidin - antibiotics
EP0207700A3 (en) Hypocholesterolemically and/or hypotriclyceridemically active rna fractions
JPS6425789A (en) Substituted amidephophonate and amidephosphate
IL92606A0 (en) Sphingenine and derivatives thereof
CS976187A1 (en) Oxigen-bridged tetrahydropyridines- parimidines and hexahydropyridines